Mammoth Biosciences Gets NIH Contract to Scale CRISPR Covid-19 Diagnostic Platform
Mammoth Biosciences’ Detectr test is the first CRISPR-based initiative to be funded by the RADx program.
Read MorePosted by Melanie Hamilton-Basich | Aug 4, 2020 | Covid 19, Uncategorized |
Mammoth Biosciences’ Detectr test is the first CRISPR-based initiative to be funded by the RADx program.
Read MorePosted by Laurie Bonner | May 28, 2020 | Covid 19, Uncategorized |
The goal is to develop an accurate, easy-to-use, fully disposable, rapid, handheld test that can be used to detect active SARS-CoV-2 infections.
Read MorePosted by | Apr 30, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Using portable heat blocks and readily available supplies, DetectR can detect the covid-19 virus from respiratory swab RNA extracts in less than 45 minutes.
Read More